Daily Respiratory Research Analysis
Three impactful respiratory studies emerged: neonatal gut microbiota composition in the first week of life was linked to hospitalizations for severe viral lower respiratory tract infections by age two; extreme heat events substantially increased pediatric respiratory, asthma, and infectious disease emergencies; and lung microbiota species turnover in cystic fibrosis predicted pulmonary exacerbations weeks before treatment. Together, they highlight prevention opportunities across the gut–lung axi
Summary
Three impactful respiratory studies emerged: neonatal gut microbiota composition in the first week of life was linked to hospitalizations for severe viral lower respiratory tract infections by age two; extreme heat events substantially increased pediatric respiratory, asthma, and infectious disease emergencies; and lung microbiota species turnover in cystic fibrosis predicted pulmonary exacerbations weeks before treatment. Together, they highlight prevention opportunities across the gut–lung axis, climate resilience, and microbiome-based early warning.
Research Themes
- Early-life gut–lung axis and respiratory infection risk
- Climate extremes and pediatric respiratory/infectious morbidity
- Microbiome dynamics as predictive biomarkers in chronic lung disease
Selected Articles
1. Investigation of associations between the neonatal gut microbiota and severe viral lower respiratory tract infections in the first 2 years of life: a birth cohort study with metagenomics.
In a UK birth cohort (n=1082 linked), higher neonatal gut microbiota alpha diversity in the first week of life was associated with reduced hospitalizations for viral lower respiratory tract infections by age two. A Bifidobacterium longum–dominant community (observed only in vaginally born infants) was linked to lower vLRTI admission rates compared with mixed or B. breve–dominant clusters. These data highlight specific bacterial signatures as potential targets for prevention.
Impact: This large, prospectively linked metagenomic cohort provides robust evidence that first-week gut microbiota composition relates to severe respiratory outcomes, nominating B. longum–dominant states as protective. It advances mechanistic prevention strategies via the gut–lung axis.
Clinical Implications: Early-life microbiome profiling could identify infants at high risk of severe viral LRTIs and inform preventive trials (e.g., maternal/infant B. longum–focused probiotics, delivery mode–informed strategies). Integration into population health programs may reduce pediatric respiratory admissions.
Key Findings
- Higher neonatal alpha diversity was associated with fewer vLRTI hospitalizations (adjusted HRs: Chao1 0.92, Shannon 0.57, Simpson 0.36).
- A Bifidobacterium longum–dominant cluster (observed only in vaginal births) had lower vLRTI admission rates; mixed and B. breve–dominant clusters showed higher rates (adjusted HR ~3.05 and 2.80 vs B. longum cluster).
- Associations persisted after adjustment using direct acyclic graph–informed confounders in Poisson mixed-effects models.
Methodological Strengths
- Prospective birth cohort with linkage to national hospital records and median 2-year follow-up.
- Shotgun metagenomic sequencing enabling species-level resolution and clustering.
- Confounder adjustment guided by directed acyclic graphs and mixed-effects modeling.
Limitations
- Observational design precludes causal inference; residual confounding possible.
- Only 34% had sequenced stool, raising selection concerns; predominantly term, healthy infants limit generalizability.
- Microbiota assessed only in the first week; dynamics beyond that period not captured.
Future Directions: Randomized trials of targeted probiotics (e.g., B. longum), maternal/infant microbiome modulation, and mechanistic studies of immune training along the gut–lung axis; replication across diverse populations and delivery modes.
BACKGROUND: Early-life gut microbiota affects immune system development, including the lung immune response (gut-lung axis). We aimed to investigate whether gut microbiota composition in neonates in the first week of life is associated with hospital admissions for viral lower respiratory tract infections (vLRTIs). METHODS: The Baby Biome Study (BBS) is a prospective birth cohort, which enrolled mother-baby pairs between Jan 1, 2016, and Dec 31, 2017, at three UK hospitals. In the present study, we only included BBS babies with a sequenced first-week stool sample and successful data linkage. Stool was collected in the first week of life for shotgun-metagenomic sequencing. We examined the following microbiota features: alpha diversity (Chao1, Shannon, and Simpson indices) and community structures (cluster-partitioning against medoids method). The participants were followed up through linkage to the Hospital Episode Statistics-Admitted Patient Care (HES-APC) database to determine vLRTI hospital admission incidence in the first 2 years of life. We used Poisson mixed-effects models for univariable and multivariable analyses to evaluate the association between microbiota features and vLRTI hospital admission incidence, adjusting for confounders identified through direct acyclic graphs. FINDINGS: 3305 (95%) of the 3476 BBS-enrolled babies for whom consent to data linkage was obtained were included in the present study. 1111 (34%) babies had a first-week sequenced stool sample, of whom 1082 (97%; 564 born vaginally and 518 born by caesarean section) were successfully linked to HES-APC, and had median follow-up of 2·0 years (IQR 1·4-2·9). Most babies were born at term (996 [92%] ≥37 weeks gestational age and 1070 [99%] >35 weeks gestational age) and healthy (1050 [97%] had no comorbidities), and 520 (48%) were female and 562 (52%) were male. Higher first-week gut microbiota alpha diversity was associated with reduced rates of vLRTI hospital admission (Chao1 Index adjusted hazard ratio [HR] 0·92 [95% CI 0·85-0·99]; Shannon Index adjusted HR 0·57 [0·33-0·98]; and Simpson Index adjusted HR 0·36 [0·11-1·20]). Three microbiota clusters were identified. Cluster 1 had a mixed composition and cluster 2 was dominated by Bifidobacterium breve, with both clusters observed in babies born vaginally and by caesarean section.
2. Extreme heat and pediatric health in a warming world: a space-time stratified case-crossover investigation in Ontario, Canada.
In Ontario (2005–2015), extreme heat episodes (≥2 consecutive days above the 99th percentile) substantially increased pediatric hospital admissions for respiratory illnesses (26%) and lower respiratory infections (50%), as well as ED visits for asthma (18%), lower respiratory infections (10%), heat-related illness (211%), heatstroke (590%), and dehydration (35%). Injury-related presentations decreased. Results support child-specific heat-health policies.
Impact: This province-wide, methodologically rigorous study quantifies pediatric respiratory and infectious risks from extreme heat, providing actionable evidence for climate adaptation in child health systems.
Clinical Implications: Pediatric care systems should implement heat-health early warning, asthma action plan reinforcement during EHEs, hydration and cooling protocols, and school/community strategies (shade, ventilation, indoor air quality) to mitigate respiratory and infectious burdens.
Key Findings
- EHEs increased pediatric hospital admissions for respiratory illnesses by 26% and lower respiratory infections by 50%; asthma admissions rose by 29%.
- ED visits increased for lower respiratory infections (10%), asthma (18%), heat-related illnesses (211%), heatstroke (590%), and dehydration (35%).
- Injury-related admissions and ED visits decreased during EHEs; no association with all-cause hospital admissions or ED visits.
Methodological Strengths
- Space-time stratified case-crossover design controlling for time-invariant confounding.
- Province-wide analysis with multiple pediatric endpoints and conditional quasi-Poisson regression.
- Robust, percentile-based, area-specific heat definitions with lag structure assessment.
Limitations
- Administrative data lack individual-level exposure and clinical detail; potential misclassification.
- Generalizability beyond Ontario climate and healthcare systems may be limited.
- Potential residual confounding (e.g., air pollutants) despite design strengths.
Future Directions: Integrate pediatric heat-health alerts with asthma and infection management pathways; evaluate targeted interventions (cooling centers, school-based measures); expand to multi-region analyses and incorporate air quality interactions.
BACKGROUND: Globally, climate change is causing frequent and severe extreme heat events (EHEs). A large body of literature links EHEs to multiple health endpoints. While children's physiology and activity patterns differ from those of adults in ways that are hypothesized to increase susceptibility to such endpoints, research gaps remain regarding the specific impacts of EHEs on child health. This study evaluated pediatric emergency healthcare utilizations associated with EHEs in Ontario. METHODS: Applying a space-time stratified case-crossover design, associations between EHEs (same-day or lagged exposure to 2 consecutive days of daily maximum temperatures above percentile thresholds) and 15 causes of pediatric emergency healthcare use in Ontario, Canada from 2005 to 2015 were analysed using conditional quasi-Poisson regression. In primary analyses, EHEs were defined as two or more consecutive days with temperatures above the 99th percentile of temperature within each respective forward sortation area (FSA). Emergency healthcare use was measured using hospital admissions as an indicator of severe outcomes, and emergency department (ED) visits as a sensitive measure of outcomes. RESULTS: Relative to non-EHE days, EHEs increased the rates of pediatric hospital admissions for respiratory illnesses by 26% (95% CI: 14-40%), asthma by 29% (16-44%); infectious and parasitic diseases by 36% (24-50%), lower respiratory infections by 50% (36-67%), and enteritis by 19% (7-32%). EHEs also increased the rates of ED visits for lower respiratory infections by 10% (0-21%), asthma by 18% (7-29%), heat-related illnesses by 211% (193-230%), heatstroke by 590% (550-622%), and dehydration by 35% (25-46%), but not for other causes. Admissions and ED visits due to injuries and transportation related injuries were negatively associated with EHEs. Neither all-cause hospital admissions nor ED visits were associated with EHEs. CONCLUSIONS: In Ontario, EHEs decreased the rates of pediatric emergency healthcare utilization for injuries and increased the rates of respiratory illnesses, asthma, heat-related illnesses, heatstroke, dehydration, infectious and parasitic diseases, lower respiratory infections, and enteritis. Tailored policies and programs that reflect the specific heat-related vulnerabilities of children to respiratory and infectious illnesses are warranted in the face of a rapidly warming climate.
3. Species turnover within cystic fibrosis lung microbiota is indicative of acute pulmonary exacerbation onset.
Using species-time relationships in longitudinal CF sputum microbiome series (n=12, ~316 days/patient), temporal species turnover (w) rose before and during pulmonary exacerbations and peaked during treatment. Departures of w-values from expected norms enabled approximation of exacerbation onset ~21 days before treatment, correlating with lung function change and highlighting personalized microbiome dynamics.
Impact: This work introduces a general ecological metric (species turnover) as an actionable, early biomarker for CF exacerbation onset, potentially enabling preemptive therapy.
Clinical Implications: Incorporating microbiome turnover monitoring into CF surveillance could trigger earlier evaluation and targeted therapy before full exacerbation, potentially reducing morbidity and preserving lung function.
Key Findings
- Species turnover (w) increased during pre-exacerbation and treatment periods, not solely due to antibiotic perturbation.
- Deviation of w from expected norms estimated exacerbation onset at 21.2 ± 8.9 days before treatment initiation.
- Higher turnover associated with greater longitudinal change in lung function; turnover patterns were highly personalized.
Methodological Strengths
- Ecological modeling (species-time relationships) applied to dense, longitudinal patient-specific microbiome series.
- Within-person analysis reduces confounding by inter-individual variability.
- Objective linkage to clinical exacerbation timing and lung function change.
Limitations
- Small sample size (n=12) limits generalizability; requires external validation.
- Sputum sampling intervals and antibiotic exposures may influence dynamics.
- Mechanistic causality between turnover and pathophysiology not established.
Future Directions: Prospective validation in larger, multi-center cohorts; integration with home sampling and digital alerts; mechanistic studies linking turnover to inflammation and pathogen dynamics.
BACKGROUND: Acute pulmonary exacerbations (PEx) are associated with increased morbidity and earlier mortality for people living with cystic fibrosis (pwCF). The most common causes of PEx in CF are by bacterial infection and concomitant inflammation leading to progressive airway damage. To draw attention to the seriousness of PEx they have been labelled as 'lung attacks', much like a 'heart attack' for acute myocardial infarction. Treatment typically starts when a pwCF presents with worsening respiratory symptoms. Hence, there is a pressing need to identify indicative biomarkers of PEx onset to allow more timely intervention. Set within an ecological framework, we investigated temporal microbiota dynamics to connect changes in the lung microbiota of pwCF to changes in disease states across a PEx event. RESULTS: Species-time relationships (STR) describe how the richness of a community changes with time, here STRs were used to assess temporal turnover (w) within the lung microbiota of each pwCF (n = 12, mean sample duration 315.9 ± 42.7 days). STRs were characterised by high interpatient variability, indicating that turnover and hence temporal organization are a personalized feature of the CF lung microbiota. Greater turnover was found to be significantly associated with greater change in lung function with time. When microbiota turnover was examined at a finer scale across each pwCF time series, w-values could clearly be observed to increase in the exacerbation period, then peaking within the treatment period, demonstrating that increases in turnover were not solely a result of perturbations caused by PEx antibiotic interventions. STR w-values have been found to have a remarkable degree of similarity for different organisms, in a variety of habitats and ecosystems, and time lengths (typically not exceeding w = 0.5). Here, we found w-values soon increased beyond that. It was therefore possible to use the departure from that expected norm up to start of treatment to approximate onset of PEx in days (21.2 ± 8.9 days across the study participants). CONCLUSIONS: Here, we illustrate that changes in turnover of the lung microbiota of pwCF can be indicative of PEx onset in considerable advance of when treatment would normally be initiated. This offers translational potential to enable early detection of PEx and consequent timely intervention. Video Abstract.